Aug 2026· Frontiers in Public Health· Vol 14· 0 citations· 25 references
Medicine
TL;DR
The machine learning-enabled auxiliary risk-stratification model, XGB, showed favorable internal performance and may provide a potential auxiliary tool for early DI-TB risk assessment, but prospective external validation is still required before routine clinical application.
Abstract
Background Disseminated tuberculosis (DI-TB) can induce multiple organ dysfunction syndrome and carries a high mortality rate. This study aimed to establish an early-warning diagnostic model to facilitate the identification of DI-TB high-risk patients and improve clinical prognosis. Methods We retrospectively enrolled 1,122 HIV-negative hospitalized patients with disseminated tuberculosis (DI-TB) or pulmonary tuberculosis (PTB) admitted to Nanjing Second Hospital. Using conventional laboratory tests and multidimensional lymphocyte subset analysis, a diagnostic model was constructed employing machine learning algorithms. Feature importance analysis was performed using the Shapley Additive Explanations (SHAP) framework. Results We screened nine significant features for model development. The XGB model demonstrated favorable diagnostic performance in the internal test set, achieving an AUC of 0.983, a Brier score of 0.025, an accuracy of 0.949, sensitivity of 0.914, specificity of 0.961, F1-score of 0.897, MCC of 0.864, NPV of 0.972, and PPV of 0.881. The SHAP interpretability system ranked features by importance, illustrating their positive or negative contributions to XGB predictions and explaining how individual features influenced model outputs. Conclusion This study developed and internally evaluated a machine learning-enabled auxiliary risk-stratification model for identifying dissemination risk among HIV-negative hospitalized TB patients. The XGB model showed favorable internal performance and may provide a potential auxiliary tool for early DI-TB risk assessment, but prospective external validation is still required before routine clinical application.
The Gradient Boosting Machine (GBM) model demonstrated superior performance on the test set, and its high specificity may reduce unnecessary confirmatory testing, while its core predictors offer biological insights into TB-associated inflammatory processes.
Yahya Khan, Lisa Sullivan, Danial Khan et al.· World Journal of Biology Pha...· 0 citations
WHO reports that only 54% of tuberculosis (TB) patients received rapid diagnostic tests at their initial presentation. Conventional laboratory methods in TB detection have high specificity (>90%) but low sensitivity (<50%). This means a large number of tuberculosis patients are missed. A better diagnostic approach is e...
Miao-Miao Zhao, Qiu-Xiang Hu, Qing Wang et al.· Medicine· 0 citations
Tuberculosis (TB) remains a major global health burden because of high infection and mortality rates, delays in diagnosis, the emergence of drug-resistant strains, and the wide variation in how the disease presents. Diagnosis of TB, estimation of the risk of multidrug resistance (MDR), and early identification of patie...
K. Kavitha, R. Subrahmanyam, P. A. Sai et al.· Conference Proceedings in Sc...· 0 citations
An interpretable XGBoost model that accurately predicts pneumonia risk in AL patients based on routine admission data is developed and validated and provides actionable risk stratification to inform preemptive diagnostic and therapeutic strategies.
W. Zhuang, Chen Huang, Xu-Dong Ma et al.· Leukemia research : a Forum...· 0 citations
Tuberculosis is the deadliest infectious disease, and treatments for multidrug-resistant tuberculosis are lengthy and toxic. By analyzing a large international database (N = 7,750), we identified patient risk phenotypes linked to unfavorable outcomes. Factors like HIV infection, age, low BMI, smoking, acid-fast bac...
M. García-Cremades, Jonathon R. Campbell, N. Strydom et al.· Nature Communications· 0 citations
A ML‐based model for FI prediction, demonstrating good predictive accuracy and strong clinical interpretability, is developed and validated and can assist clinicians in early identification of high‐risk patients and in making personalized intervention decisions, holding significant clinical value.
Jin-Ru Yang, Shu Pan, Tao Luo et al.· Health Care Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.